Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

8 clinical trials · Condition

Record	Firm	Date
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study (NCT04900623)	Jonathan Schoenfeld, MD, MPH	2021-07-02
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin (NCT04541355)	Hyunseok Kang, MD	2020-10-14
Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer (NCT04140513)	Ohio State University Comprehensive Cancer Center	2020-10-09
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma (NCT04106362)	Jonsson Comprehensive Cancer Center	2020-01-14
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT04162873)	University of Utah	2019-11-27
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin (NCT03258554)	National Cancer Institute (NCI)	2018-04-03
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer (NCT03010150)	M.D. Anderson Cancer Center	2016-12-29

Every clearance here is in the API, with alerts when new ones post.